Ad
related to: BioNTech
Search results
AstraZeneca requests European authorisation of Covid vaccine be pulled
Euronews via Yahoo News· 51 minutes agoBillions of doses of the AstraZeneca vaccine were distributed to poorer countries through a...
European Medicines Agency pulls authorization for AstraZeneca’s COVID shot, at company’s request
CBS 47 Fresno· 6 hours agoLONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 2 days agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 2 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks via Yahoo Finance· 5 days agoInvestors are always looking for stocks that are poised to beat at earnings season and BioNTech SE...
Van ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 5 days agoVan ECK Associates Corp cut its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 13.7% in the fourth quarter, according to the company in its most recent disclosure ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 hours agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
Q1 2024 BioNTech SE Earnings Call Transcript
Guru Focus· 2 days agoThank you for joining BioNTech's First Quarter 2024 Earnings Call. As a reminder, the slides we will be using on this call and the corresponding press release published this ...
BioNTech says 90% of 2024 revenues will accrue at end of year
WHTC 1450 Holland· 2 days agoFRANKFURT (Reuters) - Germany's BioNTech, whose COVID-19 vaccine in partnership with Pfizer was...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 2 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
